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Abstract
Background: The cytotoxin associated gene A (cagA), and the vacuolating cytotoxin gene A (vacA)
of Helicobacter pylori have been associated to phenotypic characteristics of virulence. The objectives
of this study were to detect the presence of cagA and to characterize the allelic variants of vacA in
63 strains of H. pylori isolated from colonized individuals with different clinical outcomes.
Methods: 38 strains were isolated from patients with non-ulcerative dyspepsia (NUD) and 25
were isolated from colonized individuals with peptic ulcers. The genotypic characterization was
carried out utilizing PCR methodology. The presence of the cagA gene was detected using two set
of primers from the middle conservative region of the cagA, and primers for the signal and middle
region were used for the genotyping of vacA
Results: The presence of cagA showed similar rates in strains from peptic ulcers (60%) and NUD
patients (55%). Also similar was the prevalence of the allelic form s1 of vacA between the strains
obtained from ulcers or NUD patients. However, the combination cagA+/vacA s1m1 was found
more frequently among the H. pylori strains from peptic ulcer patients (52%) than among strains
isolated from NUD patients (26%), this difference was statistically significant (p = 0.035).
Conclusions: The presence of either cagA or the allelic variant s1 vacA alone do not have a
predictive value as as a risk markers of severe gastric pathologies in the Chilean population.
However, being infected by a H. pylori strain with the genotype cagA+/vacA s1m1 may be associated
to an increased risk of acquiring a peptic ulcer disease.
Background
Helicobacter pylori infects about half of the world popula-
tion, but only a reduced percentage develops peptic ulcers
or gastric cancer, both conditions are strongly related with
H. pylori infection in Chile [1]. It has been suggested that
patients with severe gastroduodenal symptoms are infect-
ed with more virulent strains of H. pylori, while those in-
dividuals that just develop gastritis are infected with
strains of low pathogenic potential. cagA is one of the
markers for a pathogenicity island of ca. 40 kilobases,
which has been associated to more severe clinical out-
comes [2]. vacA codes for another important virulence fac-
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tor that induces vacuolization on eukaryotic cells in vitro,
and different allelic variants in two regions of this gene
has been described. The N-terminal signal region (s) may
occur as the alleles s1 (s1a and 1b) or s2 and the middle
region (m) is present as alleles m1 or m2. The variable
structure of this gene has been associated with differences
in the production of the cytotoxin and the clinical out-
come of the H. pylori infection [3].
In Chile, two gastroduodenal diseases, peptic ulcers and
gastric cancer, are a frequent cause of medical consulta-
tion. Moreover, serological studies have indicated that an
elevated percentage (over 70%) of asymptomatic adults
over 35 years old, are infected by H. pylori [4].
The objective of this study was to evaluate the prevalence
of the cagA gene and the allelic variants of the s and m re-
gions of the vacA gene in H. pylori strains isolated from
Chilean patients.
Methods
A total of 63 H. pylori strains were analyzed in this study.
All strains were isolated from gastric biopsies, 25 from pa-
tients with gastroduodenal ulcers, and 38 from colonized
individuals with non-ulcerative dyspepsia (NUD). H. py-
lori was identified by means of microscopic observation
and urease, catalase and oxidase tests. Isolates were finally
confirmed by PCR. The presence of the cagA gene was de-
tected by PCR using two set of primers from the middle
conservative region of the cagA: 
5'-GATAACAGGCAAGCTTTTGAGAGGGA-3' and 
5'-CCATGAATTTTTGATCCGTTCGG-3' originating a frag-
ment of 393 bp [5] and 
5'-GATAACAGGCAAGCTTTTGAGG-3' and 
5'-CTGCAAAAGATTGTTTGGCAGA-3', which yield a frag-
ment of 349 bp [6]. The genotyping of vacA was done by
PCR. For the s region, the primers 
5'-ATGGAAATACAACAAACACAC-3' and 
5'-CTGCTTGAATGCGCCAAAC-3' originated fragments of
259 bp (s1 type) or fragments of 286 bp (s2 type) [3]. For
the m region, the primers 
5'-CAATCTGTCCAATCAAGCGAG-3' and 
5'-GCGTCAAAATAATTCCAAGG-3' originated fragments
of 567 bp (m1 type), or fragments of 642 bp (m2 type)
[7]. The amplification products were evidenced through
2% agarose gel electrophoresis. Gels were stained with
ethidium bromide, and observed under UV light. Com-
parative statistical analysis was done using the chi-square
test.
Table 1: Prevalence of cagA and allelic variants of vacA on the H. pylori strains isolated from patients with ulcer or NUD
Gastroduodenal 
condition
CagA VacA
CagA + CagA - S1 S2 m1 m2 m1m2
Ulcers* 15 (60%) 10 (40%) 16 (62%) 9 (38%) 13 (52%) 11 (44%) 1 (4%)
NUD** 21 (55%) 17 (45%) 20 (53%) 18 (47%) 14 (37%) 23 (60%) 1 (3%)
*Strains isolated from ulcer patients (N = 25) **Strains isolated from NUD patients (N = 38)
Table 2: Prevalence of cagA related to the main allelic combinations of vacA.
Gastroduodenal 
condition
cagA+ cagA-
s1m1 s1m2 s2m2 s1m1 s1m2 s2m2
Ulcers* 13 (52%) 02  (8%) 01  (4%) 8 (32%)
NUD** 10 (26%) 3 (8%) 7 (18%) 4 (11%) 2 (5%) 11 (29%)
*Strains isolated from ulcer patients (N = 25) **Strains isolated from NUD patients (N = 38)BMC Gastroenterology 2002, 2 http://www.biomedcentral.com/1471-230X/2/20
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Results and Discussion
As shown in Table 1, the presence of cagA was similar in
the groups studied, 15/25 (60%) in the strains from ulcer
patients and 21/38 (55%) in the strains from NUD pa-
tients. The prevalence of the allelic variants of s1 and m1
of vacA was higher in the strains isolated from ulcer pa-
tients than in the strains from NUD patients (62% vs
53%, and 52% vs 37% respectively), however these differ-
ences were not statistically significant. The combinations
s1m1 and s2m2 A were predominant, being s1m1 more
prevalent in the strains obtained from ulcer patients (52%
in ulcer and 40% in NUD), and s2m2 more prevalent in
the strains from NUD cases (36% in ulcer and 47% in
NUD), although these differences were not statistically
significant. When the cagA and vacA genotypes were com-
bined and analyzed in relation to the clinical outcome
(Table 2), the cagA+ strains with the allelic variant s1m1
of vacA were more prevalent in the strains isolated from
ulcers patients (52%) than in the strains from NUD pa-
tients (26%), this difference was statistically significant (p
= 0.035).
Several studies, have demonstrated that the genotype var-
ies among H. pylori strains isolated from different geo-
graphic regions [8,9] and conclusions derived from one
geographic region may not be true for others. Reports
from developed countries have found that the cagA gene
and the allelic variant s1 of vacA are more prevalent
among strains of H. pylori isolated from patients with pep-
tic ulcers [2,3,10]. In South America, De Gusmao et al.
demonstrated an association between the presence of the
s1 allele and the presence of duodenal ulcer, and also an
association between the presence of the m1 allele of the
vacA gene and the presence of peptic ulcers in Brazilian
children [11]. On the other hand, reports from other geo-
graphical regions like Asian and some Latin American
countries have found no association between the presence
of cagA or the s1 allelic variant of vacA and the clinical out-
come of an H. pylori infection [6,12–15]. Thus, Yamaoka
et al. have concluded that no particular combination of
iceA, vacA, and cagA is helpful in predicting a patient's dis-
ease status [6]. In our experience, taken individually, the
presence of cagA or the allelic variant s1 of vacA do not
have a predictive value as risk markers for the develop-
ment severe gastric pathologies. However, the results pre-
sented here are somehow peculiar, since when we
considered the prevalence of cagA and the allelic variants
of vacA together, the cagA+/s1m1 combination was signif-
icantly more prevalent among the strains isolated from
peptic ulcer patients than in NUD patients. Although the
p value is near the borderline for the statistical signifi-
cance, these data may reflect a tendency, which are sup-
ported by the use of two different sets of primers to
evaluate the cagA status. These results then, suggest that in
the Chilean population, being infected by a H. pylori strain
with the genotype cagA+/vacA s1m1 may be associated to
an increased risk of acquiring an ulcer disease. The genetic
predisposition of the population, and local environmen-
tal factors, may also be important factors in the develop-
ment of diseases caused by H pylori, which may explain
the differences observed with respect to others Latin
American countries. The geographical barriers existing in
Chile might in part preserve these differences.
Conclusions
The presence of cagA or the allelic variant s1 of vacA alone
do not have a predictive value as risk markers for the de-
velopment of ulcer disease among the Chilean popula-
tion. However, being infected by a H. pylori strain with the
genotype cagA+/vacA s1m1 may increase the risk of ac-
quiring a peptic ulcer.
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